Serum fibroblast growth factor-23 levels in chronic haemodialysis patients

被引:0
|
作者
Salwa Ibrahim
Laila Rashed
机构
[1] Cairo University,Department of Medicine
[2] Cairo University,Department of Biochemistry
来源
International Urology and Nephrology | 2009年 / 41卷
关键词
Fibroblast growth factor 23; Hemodialysis; Hyperparathyroidism; Hyperphosphataemia; End-stage renal disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:163 / 169
页数:6
相关论文
共 50 条
  • [21] Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism
    Nishi, H
    Nii-Kono, T
    Nakanishi, S
    Yamazaki, Y
    Yamashita, T
    Fukumoto, S
    Ikeda, K
    Fujimori, A
    Fukagawa, M
    NEPHRON CLINICAL PRACTICE, 2005, 101 (02): : C94 - C99
  • [22] Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients
    Balci, Mustafa
    Kirkpantur, Alper
    Gulbay, Mutlu
    Gurbuz, Oguz Alp
    HEMODIALYSIS INTERNATIONAL, 2010, 14 (04) : 425 - 432
  • [23] Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
    Galvao, Joao F. de Brito
    Nagode, Larry A.
    Schenck, Patricia A.
    Chew, Dennis J.
    JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2013, 23 (02) : 134 - 162
  • [24] Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
    Vervloet, Marc G.
    van Ittersum, Frans J.
    Buttler, Rahel M.
    Heijboer, Annemieke C.
    Blankenstein, Marinus A.
    ter Wee, Piet M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (02): : 383 - 389
  • [25] Fibroblast Growth Factor-23 and Outcomes: New Answers, New Questions
    Bhan, Ishir
    Thadhani, Ravi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (04): : 523 - 525
  • [26] Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?
    Bernhard Bielesz
    Wiener klinische Wochenschrift, 2010, 122 : 194 - 197
  • [27] Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?
    Bielesz, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (7-8) : 194 - 197
  • [28] Association of Fibroblast Growth Factor-23 Level with Carotid Intima Media Thickness in Hemodialysis Patients
    Okasha, Kamal Mohammed
    Alsheekh, Mabrook Ramadan
    Kotb, Nesreen
    Alnabawy, Sherein
    Darrag, Omneya M.
    Sweilam, Mohammad
    Ramadan, Kareem Mohammed
    Sherif, Mohammed Hamed
    Aboelnasr, Mohamed Sabry
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (07): : E148 - E156
  • [29] Increased Levels of Serum Parathyroid Hormone and Fibroblast Growth Factor-23 Are the Main Factors Associated with the Progression of Vascular Calcification in Long-Hour Hemodialysis Patients
    Jean, Guillaume
    Bresson, Eric
    Lorriaux, Christie
    Mayor, Brice
    Hurot, Jean-Marc
    Deleaval, Patrick
    Chazot, Charles
    NEPHRON CLINICAL PRACTICE, 2012, 120 (03): : C132 - C138
  • [30] Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis
    Miao, Li-Ying
    Zhu, Bin
    He, Xiao-Zhou
    Liu, Jin-Feng
    Jin, Li-Na
    Li, Xiu-Rong
    Xue, Li-Na
    Huang, Tian
    Shen, Jian-Qin
    Xing, Chang-Ying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (04) : 947 - 952